Acacetin shows anti-osteosarcoma effect through AKT/GSK-3β/β-catenin signaling pathway

WEI Mengqi, YE Caihong, HUANG Huakun, YANG Chunmei, ZHANG Lulu, LUO Jinyong

PDF(1971 KB)
PDF(1971 KB)
Tumor ›› 2022, Vol. 42 ›› Issue (06) : 388-398. DOI: 10.3781/j.issn.1000-7431.2022.2202-0143
Original Research

Acacetin shows anti-osteosarcoma effect through AKT/GSK-3β/β-catenin signaling pathway

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 42(06): 388-398 https://doi.org/10.3781/j.issn.1000-7431.2022.2202-0143

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1971 KB)

Accesses

Citation

Detail

Sections
Recommended

/